Abstract:A definitive test for developmental totipotency of mouse malignant teratocarcinoma cells was conducted by cloning singly injected cells in genetically marked blastocysts. Totipotency was conclusively shown in an adult mosaic female whose tumor-strain cells had made substantial contributions to all of the wide range of its somatic tissues analyzed; the clonally propagated cell lineage had therefore differentiated in numerous normal directions. The test cells were from "cores" of embryoid bodies of a euploid, chromosomally male (X/Y), ascites tumor grown only in vivo by transplantation for 8 years. The capacity of cells from the same source to differentiate, in a phenotypic male, into reproductively functional sperms, has been shown in our previous experiments [(1975) Proc. Nat. Acad. Sci. USA 72, 3585-3589]. Cells from this transplant line therefore provide material suitable for projected somatic and germ-line genetic analyses of mammalian differentiation based on "cycling" of mutation-carrying tumor cells through developing embryos. In some animals obtained from single-cell injections tumor-derived cells were sporadically distributed in developmentally unrelated tissues. These cases can be accounted for by delayed and haphazard cellular integration, and by a marked degree of sustained cellular developmental flexibility in early mammalian development, irrespective of certain classical "germ-layer" designations. All mosaic mice obtained have thus far been free of teratomas. In one case, the injected stem cell contributed only to the pancreas and gave rise to a malignancy resembling pancreatic adenocarcinoma. The high modal frequency of euploidy in these individually tested cells thus tends to indicate that a near-normal chromosome complement is sufficient for total restoration of orderly gene expression in a normal embryonic environment; it may also be necessary for teratoma stem-cell proliferation to be terminated there.

The rules of the totipotency treasure hunt

The regulation of totipotency transcription: Perspective from in vitro and in vivo totipotency

Evaluating totipotency using criteria of increasing stringency

Molecular mechanisms underlying totipotency

Totipotency continuity from zygote to early blastomeres: a model under revision

Oct-4: Lessons of Totipotency from Embryonic Stem Cells

Hallmarks of Totipotent and Pluripotent Stem Cell States.

Cell totipotency: molecular features, induction, and maintenance.

Transition from totipotency to pluripotency in mice: insights into molecular mechanisms

Totipotency segregates between the sister blastomeres of two-cell stage mouse embryos

Induction of mouse totipotent stem cells by a defined chemical cocktail

Stem Cell Terminology and ‘Synthetic' Embryos: A New Debate on Totipotency, Omnipotency, and Pluripotency and How It Relates to Recent Experimental Data

Epigenetic reprogramming in the transition from pluripotency to totipotency

SELTP assembled battery drives totipotency of somatic plant cell.

Chromatin structure in totipotent mouse early preimplantation embryos

Derivation of totipotent-like stem cells with blastocyst-like structure forming potential

Totipotency of mouse zygotes extends to single blastomeres of embryos at the four-cell stage

Capture of Totipotency in Mouse Embryonic Stem Cells in the Absence of Pdzk1

Acquisition of 2C-like totipotency through defined maternal-effect factors

Molecular Mechanisms of Pluripotency and Reprogramming

Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts